Invention Grant
- Patent Title: Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
- Patent Title (中): 芳基二氢吡啶酮和哌啶酮MGAT2抑制剂
-
Application No.: US13688584Application Date: 2012-11-29
-
Publication No.: US08791091B2Publication Date: 2014-07-29
- Inventor: Huji Turdi , Jon J. Hangeland , R. Michael Lawrence , Saleem Ahmad , Wei Meng , Robert Paul Brigance , Pratik Devasthale , Guohua Zhao
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/4418 ; A61K45/06 ; A61K31/438 ; A61K31/4439 ; A61K31/5377 ; C07D401/04 ; C07D413/04 ; C07D413/14 ; C07F9/59 ; C07D401/14 ; C07D211/90 ; C07D221/20
Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Public/Granted literature
- US20130143843A1 ARYL DIHYDROPYRIDINONE AND PIPERIDINONE MGAT2 INHIBITORS Public/Granted day:2013-06-06
Information query
